Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 3834283, 7 pages
http://dx.doi.org/10.1155/2016/3834283
Research Article

The Protective Effect of Low-Dose Ethanol on Myocardial Fibrosis through Downregulating the JNK Signaling Pathway in Diabetic Rats

1Department of Physiology, Bengbu Medical College, 2600 Dong Hai Avenue, Bengbu 233030, China
2Department of Epidemiology and Statistics, Bengbu Medical College, 2600 Dong Hai Avenue, Bengbu 233030, China

Received 6 April 2016; Revised 30 June 2016; Accepted 3 July 2016

Academic Editor: Nikolaos Papanas

Copyright © 2016 Ying Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Mohan, Y. K. Seedat, and R. Pradeepa, “The rising burden of diabetes and hypertension in southeast Asian and African regions: need for effective strategies for prevention and control in primary health care settings,” International Journal of Hypertension, vol. 2013, Article ID 409083, 14 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-F. Hu, G.-J. Zhang, L. Wang et al., “Ethanol at low concentration attenuates diabetes induced lung injury in rats model,” Journal of Diabetes Research, vol. 2014, Article ID 107152, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. P. E. Ronksley, S. E. Brien, B. J. Turner, K. J. Mukamal, and W. A. Ghali, “Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis,” The British Medical Journal, vol. 342, no. 3, article d671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. E. Brien, P. E. Ronksley, B. J. Turner, K. J. Mukamal, and W. A. Ghali, “Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies,” BMJ, vol. 342, article d636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-L. Zheng, F. Lian, Q. Shi et al., “Alcohol intake and associated risk of major cardiovascular outcomes in women compared with men: a systematic review and meta-analysis of prospective observational studies,” BMC Public Health, vol. 15, article 773, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Roerecke and J. Rehm, “Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers,” BMC Medicine, vol. 12, article 182, 2014. View at Publisher · View at Google Scholar
  7. L. L. Husemoen, T. Jørgensen, K. Borch-Johnsen, T. Hansen, O. Pedersen, and A. Linneberg, “The association of alcohol and alcohol metabolizing gene variants with diabetes and coronary heart disease risk factors in a white population,” PLoS ONE, vol. 5, no. 8, article e11735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Gao, H.-J. Wang, X.-M. Wang et al., “Activation of ALDH2 with ethanol attenuates diabetes induced myocardial injury in rats,” Food and Chemical Toxicology, vol. 56, pp. 419–424, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. V. Holmes, C. E. Dale, L. Zuccolo et al., “Association between alcohol and cardiovascular disease: mendelian randomisation analysis based on individual participant data,” British Medical Journal, vol. 349, Article ID g4164, 2014. View at Publisher · View at Google Scholar
  10. Z. Xie, C. He, and M.-H. Zou, “AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy,” Autophagy, vol. 7, no. 10, pp. 1254–1255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Ren, “Acetaldehyde and alcoholic cardiomyopathy: lessons from the ADH and ALDH2 transgenic models,” Novartis Foundation Symposium, vol. 285, pp. 69–199, 2007. View at Google Scholar
  12. J. Wang, H. Wang, P. Hao et al., “Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats,” Molecular Medicine, vol. 17, no. 3-4, pp. 172–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Zhang, S. A. Babcock, N. Hu, J. R. Maris, H. Wang, and J. Ren, “Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function,” BMC Medicine, vol. 10, article 40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-J. Wang, P.-F. Kang, W.-J. Wu et al., “Changes in cardiac mitochondrial aldehyde dehydrogenase 2 activity in relation to oxidative stress and inflammatory injury in diabetic rats,” Molecular Medicine Reports, vol. 8, no. 2, pp. 686–690, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Pan, Y. Wang, Y. Zhao et al., “Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy,” Diabetes, vol. 63, no. 10, pp. 3497–3511, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-J. Li, L. Lv, H. Li, and D.-M. Yu, “Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid,” Cardiovascular Diabetology, vol. 11, article 73, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Zhou, Y.-J. Li, M. Wang et al., “Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes,” Acta Pharmacologica Sinica, vol. 32, no. 8, pp. 999–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Kaneto, T.-A. Matsuoka, N. Katakami et al., “Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes,” Current Molecular Medicine, vol. 7, no. 7, pp. 674–686, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kaneto, G. Xu, N. Fujii, S. Kim, S. Bonner-Weir, and G. C. Weir, “Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression,” Journal of Biological Chemistry, vol. 277, no. 33, pp. 30010–30018, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Yu, X.-J. Jia, Q.-F. Zong et al., “Remote ischemic postconditioning protects the heart by upregulating ALDH2 expression levels through the PI3K/Akt signaling pathway,” Molecular Medicine Reports, vol. 10, no. 1, pp. 536–542, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Ren and J. R. Sowers, “Application of a novel curcumin analog in the management of diabetic cardiomyopathy,” Diabetes, vol. 63, no. 10, pp. 3166–3168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Bildirici, D. Ural, E. Acar, A. Agacdiken, and E. Ural, “Diagnostic value of poor R-wave progression in electrocardiograms for diabetic cardiomyopathy in type 2 diabetic patients,” Clinical Cardiology, vol. 33, no. 9, pp. 559–564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Kayama, U. Raaz, A. Jagger et al., “Diabetic cardiovascular disease induced by oxidative stress,” International Journal of Molecular Sciences, vol. 16, no. 10, pp. 25234–25263, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Baik, N. H. Cho, S. H. Kim, B.-G. Han, and C. Shin, “Genome-wide association studies identify genetic loci related to alcohol consumption in Korean men,” The American Journal of Clinical Nutrition, vol. 93, no. 4, pp. 809–816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Flensborg-Madsen, J. Knop, E. L. Mortensen, U. Becker, and M. Grønbæk, “Amount of alcohol consumption and risk of developing alcoholism in men and women,” Alcohol and Alcoholism, vol. 42, no. 5, pp. 442–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Flensborg-Madsen, U. Becker, M. Grønbæk, J. Knop, L. Sher, and E. L. Mortensen, “Alcohol consumption and later risk of hospitalization with psychiatric disorders: Prospective Cohort Study,” Psychiatry Research, vol. 187, no. 1-2, pp. 214–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Deutscher, H. E. Rockette, and V. Krishnaswami, “Evaluation of habitual excessive alcohol consumption on myocardial infarction risk in coronary disease patients,” American Heart Journal, vol. 108, no. 4, part 1, pp. 988–995, 1984. View at Publisher · View at Google Scholar · View at Scopus
  28. V. G. Athyros, E. N. Liberopoulos, D. P. Mikhailidis et al., “Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort,” Angiology, vol. 58, no. 6, pp. 689–697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-Z. Zhou, J. S. Karliner, and M. O. Gray, “Moderate alcohol consumption induces sustained cardiac protection by activating PKC-ε and Akt,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 283, no. 1, pp. H165–H174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sun, Y. Zou, P. Wang et al., “Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice,” Journal of the American Heart Association, vol. 3, no. 5, Article ID e000779, 2014. View at Google Scholar · View at Scopus
  31. Y. Yu, P.-F. Kang, H.-H. Li et al., “Effects of activation of ALDH2 by ethanol on the expression of JNK in kidney of diabetic rats,” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 30, no. 3, pp. 270–273, 2014. View at Google Scholar · View at Scopus
  32. G. Pearson, F. Robinson, T. Beers Gibson et al., “Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions,” Endocrine Reviews, vol. 22, no. 2, pp. 153–183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Omura, M. Yoshiyama, R. Matsumoto et al., “Role of c-Jun NH2-terminal kinase in G-protein-coupled receptor agonist-induced cardiac plasminogen activator inhibitor-1 expression,” Journal of Molecular and Cellular Cardiology, vol. 38, no. 4, pp. 583–592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. G.-H. Hao, X.-L. Niu, D.-F. Gao, J. Wei, and N.-P. Wang, “Agonists at PPAR-γ suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts,” British Journal of Pharmacology, vol. 153, no. 7, pp. 1409–1419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Kaneto and T.-A. Matsuoka, “Involvement of oxidative stress in suppression of insulin biosynthesis under diabetic conditions,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 13680–13690, 2012. View at Publisher · View at Google Scholar · View at Scopus